Europe — EMA
Moxonidine Generics [uk]
GNH USA supplies Moxonidine Generics [uk] (Moxonidine), a imidazoline receptor agonist for hypertension. Request a quote for global supply.
Request sourcing
What is Moxonidine?
Moxonidine, the active ingredient in Moxonidine Generics [uk], is an imidazoline receptor agonist presented as an oral tablet for oral use. It is used to lower blood pressure in adults with hypertension.
GNH USA supplies Moxonidine Generics [uk] as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Moxonidine used for?
Moxonidine acts on central sympathetic pathways to control elevated blood pressure.
Essential hypertension: lowers systolic and diastolic pressure in primary hypertension. Resistant hypertension: may be added when blood pressure remains uncontrolled despite other agents. Hypertension with sympathetic overactivity: reduces central sympathetic outflow to improve blood‑pressure control.
What are the side effects of Moxonidine?
Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.
Common Side Effects: - Dry mouth - Fatigue or drowsiness - Dizziness or light‑headedness - Headache - Nausea - Constipation
Serious or Rare Side Effects: - Severe hypotension - Bradycardia - Allergic reactions (rash, swelling, anaphylaxis) - Hepatic dysfunction - Cardiac arrhythmias - Syncope or fainting
What precautions apply to Moxonidine?
Before initiating therapy, clinicians should consider several safety aspects.
Monitor blood pressure regularly: adjust dose if excessive fall occurs. Assess renal function: dose may need adjustment in renal impairment. Avoid abrupt discontinuation: taper to prevent rebound hypertension. Caution in patients with cardiovascular disease: watch for bradycardia or hypotension. Pregnancy and lactation: consult a specialist as safety data are limited. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.
What does Moxonidine interact with?
Moxonidine can interact with other medicines that affect blood pressure or the central nervous system.
Major Interactions (Avoid): - Concomitant use with other central antihypertensives (e.g., clonidine) may cause excessive hypotension. - Co‑administration with MAO inhibitors can potentiate blood‑pressure lowering effects. - Strong CYP2D6 inhibitors (if applicable) may increase plasma levels.
Moderate Interactions (Monitor Closely): - Diuretics may enhance antihypertensive response; monitor electrolytes. - Beta‑blockers can have additive effects on heart rate and blood pressure. - Alcohol may increase dizziness and risk of falls.
